首页> 外文OA文献 >Antitumor effect of the tyrosine kinase inhibitor nilotinib on gastrointestinal stromal tumor (GIST) and imatinib-resistant GIST cells.

【2h】

Antitumor effect of the tyrosine kinase inhibitor nilotinib on gastrointestinal stromal tumor (GIST) and imatinib-resistant GIST cells.

机译：酪氨酸激酶抑制剂尼罗替尼对胃肠道间质瘤（GIsT）和伊马替尼耐药GIsT细胞的抗肿瘤作用。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hiroyuki Sako; Kazumasa Fukuda; Yoshiro Saikawa; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Hirohumi Kawakubo; Hiroya Takeuchi; Tai Ohmori; Yuko Kitagawa;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Discovery of Potent, Selective Stem Cell Factor Receptor/Platelet Derived Growth Factor Receptor Alpha (c-KIT/PDGFR alpha) Dual Inhibitor for the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) [J] . Lu Yanli, Mao Fei, Li Xiaokang, Journal of Medicinal Chemistry . 2017,第12期

机译：发现有效，选择性干细胞因子受体/血小板衍生的生长因子受体α（C-KIT / PDGFRα）双抑制剂，用于治疗伊马替尼抗性胃肠肿瘤肿瘤（GIST）
2. Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials [J] . Lile Wu, Zhongqiang Zhang, Hongliang Yao, Drug Design, Development and Therapy . 2014,第1期

机译：第二代酪氨酸激酶抑制剂在伊马替尼耐药胃肠道间质瘤中的临床疗效：近期临床试验的荟萃分析
3. Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST) [J] . Christophe Le Tourneau, Eric Raymond, Sandrine Faivre Therapeutics and Clinical Risk Management . 2007,第2期

机译：舒尼替尼：一种新型的酪氨酸激酶抑制剂。简述其在治疗肾癌和胃肠道间质瘤（GIST）中的治疗潜力
4. SHORT-TERM TUMOR RESPONSE TO TYROSINE KINASE INHIBITORS VERSUS LONG-TERM SURVIVAL IN MAST CELL TUMORS: FOLLOW-UP DATA FROM A PIVOTAL FIELD STUDY WITH MASITINIB [C] . Olivier Hermine Annual Conference of the Veterinary Cancer Society . 2009

机译：短期肿瘤对酪氨酸激酶抑制剂的反应与肥大细胞肿瘤的长期存活：来自Masitinib的关键田间研究的后续数据
5. Analysis of pp60c-src and pp62c-yes intracellular protein tyrosine kinase function in colon tumor cell growth regulation using herbimycin A, a tyrosine kinase specific inhibitor. [D] . Garcia, Roy. 1995

机译：使用酪氨酸激酶特异性抑制剂除草霉素A分析pp60c-src和pp62c-yes细胞内蛋白酪氨酸激酶在结肠肿瘤细胞生长调节中的功能。
6. Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells [O] . Hiroyuki Sako, Kazumasa Fukuda, Yoshiro Saikawa, -1

机译：酪氨酸激酶抑制剂尼罗替尼对胃肠道间质瘤（GIST）和伊马替尼耐药的GIST细胞的抗肿瘤作用。
7. Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST) [O] . Daruka Mahadevan, Noah Theiss, Carla Morales, 2014

机译：新型受体酪氨酸激酶靶向组合疗法用于伊替尼抗性胃肠肿瘤（GIST）

Antitumor effect of the tyrosine kinase inhibitor nilotinib on gastrointestinal stromal tumor (GIST) and imatinib-resistant GIST cells.

著录项

引文网络

相似文献

相关主题

期刊订阅